VitaSpring Biomedical Co (VitaSpring Biomedical Co) EV-to-FCF : -13,712.14 (As of May. 03, 2024)

VitaSpring Biomedical Co EV-to-FCF Chart

VitaSpring Biomedical Co Quarterly Data
	Jan18	Apr18	Jul18	Oct18	Jan19	Apr19	Jul19	Oct19	Jan20	Apr20	Jul20	Oct20	Jan21	Apr21	Jul21	Oct21	Jan22	Apr22	Jul22	Oct22
EV-to-FCF	Get a 7-Day Free Trial															13,228.74	240,969.75	-10,258.75	-5,496.67	-12,726.67

Competitive Comparison of VitaSpring Biomedical Co's EV-to-FCF

For the Biotechnology subindustry, VitaSpring Biomedical Co's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

VitaSpring Biomedical Co's EV-to-FCF Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, VitaSpring Biomedical Co's EV-to-FCF distribution charts can be found below:

* The bar in red indicates where VitaSpring Biomedical Co's EV-to-FCF falls into.

VitaSpring Biomedical Co EV-to-FCF Calculation

VitaSpring Biomedical Co's EV-to-FCF for today is calculated as:

VitaSpring Biomedical Co's current Enterprise Value is $3,304.63 Mil.
VitaSpring Biomedical Co's Free Cash Flow for the trailing twelve months (TTM) ended in Oct. 2022 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.24 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

VitaSpring Biomedical Co  (OTCPK:VSBC) EV-to-FCF Explanation

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

VitaSpring Biomedical Co's PE Ratio for today is calculated as:

VitaSpring Biomedical Co's share price for today is $16.00.
VitaSpring Biomedical Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Oct. 2022 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.004.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.

VitaSpring Biomedical Co EV-to-FCF Related Terms

Thank you for viewing the detailed overview of VitaSpring Biomedical Co's EV-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.

VitaSpring Biomedical Co (VitaSpring Biomedical Co) Business Description